Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - National Acad Sciences
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
[PDF][PDF] Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutza, L Hlatkyc, E Rietmanc, JA Tuszynskia - PNAS, 2012 - researchgate.net
Background Cancer can be viewed as a systems disease with potentially multiple causes for
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …
Molecular signaling network complexity is correlated with cancer patient survivability.
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - europepmc.org
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - cir.nii.ac.jp
抄録< jats: p> The 5-y survival for cancer patients after diagnosis and treatment is strongly
dependent on tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y …
dependent on tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y …
Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - ui.adsabs.harvard.edu
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
[PDF][PDF] Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutza, L Hlatkyc, E Rietmanc, JA Tuszynskia - PNAS, 2012 - academia.edu
Background Cancer can be viewed as a systems disease with potentially multiple causes for
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …
[引用][C] Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - PROCEEDINGS OF THE …, 2012 - iris.polito.it
Molecular signaling network complexity is correlated with cancer patient survivability/
Breitkreutz, Dylan; Hlatky, Lynn; Rietman, Edward; Tuszynski, Jacek A..-In: PROCEEDINGS …
Breitkreutz, Dylan; Hlatky, Lynn; Rietman, Edward; Tuszynski, Jacek A..-In: PROCEEDINGS …
[HTML][HTML] Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - ncbi.nlm.nih.gov
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutz, L Hlatky, E Rietman… - Proceedings of the …, 2012 - pubmed.ncbi.nlm.nih.gov
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
tumor type. Prostate cancer patients have a> 99% chance of survival past 5 y after …
[PDF][PDF] Molecular signaling network complexity is correlated with cancer patient survivability
D Breitkreutza, L Hlatkyc, E Rietmanc, JA Tuszynskia - PNAS, 2012 - academia.edu
Background Cancer can be viewed as a systems disease with potentially multiple causes for
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …
any cancer site (7–9). The behavior of cancer cells is governed and coordinated by …